A Safety and MORAb-028 Dose Determination Study in Subjects With Metastatic Melanoma

NCT01212276 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
18
Enrollment
INDUSTRY
Sponsor class

Stopped Sponsor terminated protocol

Conditions

Interventions

Sponsor

Morphotek